Equity Analysis

Quarterly Results

    Glaxosmithkline Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Multinational
    BSE Code
    ISIN Demat
    Book Value()
    500660
    INE159A01016
    98.8545682
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GLAXO
    48.63
    38700.81
    EPS(TTM)
    Face Value()
    Div & Yield %:
    46.98
    10
    1.4
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales1000.05811.00910.87
Other Operating Income0.000.000.00
Other Income 36.8835.8532.27
Total Income1036.93846.85943.14
Total Expenditure 681.10581.58655.56
PBIDT355.83265.27287.58
Interest 0.270.370.77
PBDT355.56264.90286.81
Depreciation16.8616.4118.10
Tax97.4663.3361.16
Fringe Benefit Tax0.000.000.00
Deferred Tax-7.453.5114.47
Reported Profit After Tax248.69181.65193.08
Extra-ordinary Items 3.340.001.72
Adjusted Profit After Extra-ordinary item245.35181.65191.36
EPS (Unit Curr.)14.4510.7211.29
EPS (Adj) (Unit Curr.)14.4510.7211.29
Calculated EPS (Unit Curr.)14.6810.7211.40
Calculated EPS (Adj) (Unit Curr.)14.6810.7211.40
Calculated EPS (Ann.) (Unit Curr.)58.7242.8945.59
Calculated EPS (Adj) (Ann.) (Unit Curr.)58.7242.8945.59
Book Value (Unit Curr.)0.000.000.00
Dividend (%)120.000.000.00
Equity169.41169.41169.41
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)35.5832.7131.57
PBDTM(%)35.5532.6631.49
PATM(%)24.8722.4021.20
Dividend Per Share(Rs)12.000.000.00
Diluted EPS14.6810.7211.39